Cure8 research brief
Why This Matters
Elevated pancreatic enzymes are relatively common in IBD and can reflect very different conditions (benign asymptomatic elevations, pancreatitis variants, or autoimmune pancreatitis). Recognizing phenotype-specific patterns helps avoid unnecessary treatment changes and guides appropriate diagnostic testing.
Who Should Pay Attention
Clinicians (gastroenterologists), researchers studying IBD complications/biomarkers, and adult IBD patients with unexplained enzyme elevations
Study Snapshot
What To Know
The PANDORA multicenter analysis included 148 IBD patients with pancreatic enzyme elevations and categorized them into three phenotypes. Most patients (≈74%) were asymptomatic when enzymes were first noted. Marked elevations (≥3× upper limit of normal) were uncommon overall but more frequent in the recAP group.
Crohn’s disease cases more often coincided with clinically active intestinal disease, while in ulcerative colitis the work-up more often led to imaging and detection of autoimmune pancreatitis. Imaging approaches and management (including drug withdrawal) varied by phenotype; confirmed drug-related cases were rare.
Keep In Mind
Registry-based retrospective design; summary drawn from the article abstract only. The study categorizes cases into predefined phenotypes and reports diagnostic/management patterns rather than intervention outcomes.
Source Details
Review the original publication for the complete reporting, methods, and context.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.